These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6803572)

  • 1. Partial thromboplastin time in the presence of heparin: a rapid polybrene neutralization method.
    Israels ED
    Am J Clin Pathol; 1982 Mar; 77(3):321-4. PubMed ID: 6803572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of Factor XII clotting activity in heparinized plasma.
    Lämmle B; Tran TH; Duckert F
    Am J Clin Pathol; 1983 Oct; 80(4):474-7. PubMed ID: 6624710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the KC10 semi-automatic modular clot detection device].
    Crespo B; Ankri A; Lesty C
    Nouv Rev Fr Hematol (1978); 1983; 25(2):113-21. PubMed ID: 6408609
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic.
    McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ
    Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric reference intervals for seven common coagulation assays.
    Flanders MM; Crist RA; Roberts WL; Rodgers GM
    Clin Chem; 2005 Sep; 51(9):1738-42. PubMed ID: 16120957
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR; McIntyre OR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
    [No Abstract]   [Full Text] [Related]  

  • 11. Bovine plasma thromboplastin antecedent (Factor XI) deficiency.
    Kociba GJ; Ratnoff OD; Loeb WF; Wall RL; Heider LE
    J Lab Clin Med; 1969 Jul; 74(1):37-41. PubMed ID: 5256172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prothromboplastin factor group (factors VIII, IX, XI, XII)--interpretation of the test results].
    Kagami M
    Nihon Rinsho; 1973; 31():1721-33. PubMed ID: 4795303
    [No Abstract]   [Full Text] [Related]  

  • 13. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.
    Saito H; Ratnoff OD; Donaldson VH
    Circ Res; 1974 May; 34(5):641-51. PubMed ID: 4826936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic peptide substrate assays for hemostasis testing.
    Zolton RP
    Adv Clin Chem; 1986; 25():117-68. PubMed ID: 2940818
    [No Abstract]   [Full Text] [Related]  

  • 16. A new principle in heparin assaying based on partial neutralization of heparin with polybrene.
    Talstad I
    Thromb Res; 1980 May 1-15; 18(3-4):485-91. PubMed ID: 7414543
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation defects in acute promyelocytic leukemia.
    Rand JJ; Moloney WD; Sise HS
    Arch Intern Med; 1969 Jan; 123(1):39-47. PubMed ID: 5248747
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins.
    Cumming AM; Jones GR; Wensley RT; Cundall RB
    Thromb Res; 1986 Jan; 41(1):43-56. PubMed ID: 3961726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Stage Factor VIII Assays.
    Duncan E; Rodgers S
    Methods Mol Biol; 2017; 1646():247-263. PubMed ID: 28804834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Easy Method to Eliminate the Effect of Lupus Anticoagulants in the Coagulation Factor Assay.
    Tang N; Yin S
    Clin Lab; 2016 Jul; 62(7):1363-1365. PubMed ID: 28164630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.